Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
Mycobacterium tuberculosis infection is one of many opportunistic infections in renal transplant recipients, arising either from reactivation of latent infection or de novo infection, occasionally donor derived. M. tuberculosis hepatitis has never been reported in patients who have received alemtuzu...
Saved in:
Main Authors: | W. Bosch, N. Poowanawittayakom, K. Chaikriangkrai, J. Mendez, W. C. Hellinger, T. A. Gonwa, M. Krishna, S. Pungpapong |
---|---|
Other Authors: | Mayo Clinic in Jacksonville, Florida |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/32548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The use of alemtuzumab (Campath 1H) in organ transplant recipients
by: Calne, S.R.
Published: (2016) -
Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
by: Vathsala, A., et al.
Published: (2011) -
Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
by: Vathsala, A, et al.
Published: (2022) -
Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient
by: Abhasnee Sobhonslidsuk, et al.
Published: (2018) -
Infections in Paediatric Renal Transplant Recipients
by: Ho, C.L., et al.
Published: (2011)